Table I.
Novel mlo alleles
| Allele | Mutant IDsa | Mutational Event at Mlo | Effect on MLO Protein | Protein Domain Affected | Bgh Resistance | Mutagen |
|---|---|---|---|---|---|---|
| mlo-12 | Do 4122 | C1396 → A | F240 → L | Second intracellular loop | Partial | Nitrosomethylurea |
| mlo-16 | Do 2376 | G1917 → Ab | Not applicable | Not applicable | Full | Ethymethane sulfonate (EMS) |
| mlo-27 | Do 2021c | G2004 → A | G318 → E | Third intracellular loop | Full | EMS |
| mlo-28 | Do 4228 | C1224 → T | T222 → I | Second intracellular loop | Partial | NaN3 |
| mlo-29 | This study | C2051 → T | P334 → L | Third intracellular loop | Full | NaN3 |
| mlo-30 | Do 2234, 2235 | A2242 → Td | Δ 6 amino acids | C terminus (intracellular) | Full | EMS |
Nucleotide nos. based on the genomic Mlo DNA sequence starting from the translational start site (ATG).
According to Habekuss and Hentrich (1988).
Nucleotide substitution in the conserved 3′ splice site of intron 9.
Also Do 2002, 2003, 2004, 2005, 2014, 2015, 2016, and 2019.
Nucleotide substitution in the conserved 3′ splice site of intron 11.